MOLECULAR STUDY OF CALR GENE: MYELOPROLIFERATIVE NEOPLASMS (MPN) WITH NEGATIVE PHILADELPHIA AND JAK2/V617F

被引：0
|
作者：
Culurgioni, F. [1 ]
Musiu, C. [1 ]
Uda, S. [1 ]
Benziane, A. [1 ]
Pettinau, M. [1 ]
Usala, E. [1 ]
Cabras, M. G. [1 ]
机构：
[1] Ctr Trapianti Midollo Osseo PO A Businco Ao Brotz, Unita Operat Ematol, Cagliari, Italy
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PU039
引用
收藏
页码：167 / 168
页数：2
相关论文
共 50 条
  • [21] JAK2 V617F Mutation Prevalence in Myeloproliferative Neoplasms in Pernambuco, Brazil
    da Silva, Rafael Ramos
    Domingues Hatzlhofer, Betania Lucena
    de Faria Machado, Cintia Gonsalves
    de Melo Lima, Aleide Santos
    de Albuquerque, Dulcineia Martins
    Nunes dos Santos, Magnun Nueldo
    Fertrin, Kleber Yotsumoto
    Costa, Fernando Ferreira
    Araujo, Aderson da Silva
    Cavalcanti Bezerra, Marcos Andre
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2012, 16 (07) : 802 - 805
  • [22] New advances in the role of JAK2 V617F mutation in myeloproliferative neoplasms
    Zhang, Yongchao
    Zhao, Yue
    Liu, YuSi
    Zhang, Minyu
    Zhang, Jihong
    CANCER, 2024, 130 (24) : 4229 - 4240
  • [23] Detection of JAK2 V617F mutation increases the diagnosis of myeloproliferative neoplasms
    Zhang, Shu-Peng
    Li, Hui
    Lai, Ren-Sheng
    ONCOLOGY LETTERS, 2015, 9 (02) : 735 - 738
  • [24] Analysis of JAK2 V617F mutation in Tunisian patients with myeloproliferative neoplasms
    Chadi, Soumaya
    Dhaouadi, Tarak
    Sfar, Imen
    Baccouche, Hela
    Nabli, Rym
    Ben Romdhane, Neila
    Ben Abdallah, Taieb
    Gorgi, Yousr
    EUROPEAN JOURNAL OF INFLAMMATION, 2021, 19
  • [25] Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN)
    Zulkeflee, Razan Hayati
    Zulkafli, Zefarina
    Johan, Muhammad Farid
    Husin, Azlan
    Islam, Md Asiful
    Hassan, Rosline
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (14)
  • [26] THROMBOEMBOLIC AND HEMORRHAGIC COMPLICATIONS AND JAK2 V617F MUTATION POSITIVITY IN PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISEASES
    Unubol, M.
    Yavsoglu, I.
    Bozkurt, G.
    Kadikoylu, G.
    Bolaman, Z.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 590 - 590
  • [27] JAK2 V617F mutation and the myeloproliferative disorders
    Vainchenker, William
    Casadevall, Nicole
    HEMATOLOGIE, 2006, 12 (01): : 3 - 7
  • [28] The JAK2 V617F mutation in the myeloproliferative disorders
    Sale, MA
    Awan, A
    Lucas, GS
    Yin, JAL
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 33 - 33
  • [29] GLS in Philadelphia-negative and JAK2 V617F-driven myeloproliferative neoplasms (MPNs).
    Ciboddo, Michele
    Yan, George
    Coen, Chad
    Dowgielewicz, Jonathan
    Blaylock, Hunter
    Arellano, Nicole S.
    Zawieracz, Katarzyna
    Rosencrance, Alex
    Casetti, Ilaria C.
    Borsani, Oscar
    Catricala, Silvia
    Vanni, Daniele
    Saygin, Caner
    McNerney, Megan
    Faubert, Brandon
    Pietra, Daniela
    Rumi, Elisa
    Elf, Shannon Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] The V617F JAK2 mutation and the myeloproliferative disorders
    Percy, MJ
    McMullin, MF
    HEMATOLOGICAL ONCOLOGY, 2005, 23 (3-4) : 91 - 93
12345